BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11598617)

  • 1. Another issue in traditional medical therapy for congenital adrenal hyperplasia.
    Arisaka O; Numata M; Hoshi M; Kanazawa S
    J Pediatr; 2001 Oct; 139(4):610. PubMed ID: 11598617
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
    Job JC; Canlorbe P; Lambertz J; Courouble P; Rossier A
    Ann Pediatr (Paris); 1970; 17(6):426-31. PubMed ID: 5421325
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth and development: congenital adrenal hyperplasia-glucocorticoids and height.
    Speiser PW
    Nat Rev Endocrinol; 2010 Jan; 6(1):14-5. PubMed ID: 20010965
    [No Abstract]   [Full Text] [Related]  

  • 4. [Predicting factors of the final height in 21-hydroxylase deficiency].
    Bachega TA
    Arq Bras Endocrinol Metabol; 2005 Dec; 49(6):867-9. PubMed ID: 16544007
    [No Abstract]   [Full Text] [Related]  

  • 5. [Patterns of growth in congenital adrenal hyperplasia. Correlation between glucocorticoid therapy and stature].
    Igea JM; Lóridan L; Martul P; Ferrández A; Mayayo E; Rodríguez M; Oyarzábal M; Elcarte R; Luzuriaga C
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():9-12. PubMed ID: 3272842
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
    Aycan Z; Ocal G; Berberoglu M; Cetinkaya E; Adiyaman P; Evliyaoglu O
    J Pediatr Endocrinol Metab; 2006 Mar; 19(3):245-51. PubMed ID: 16607925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone deficiency in salt-losing congenital adrenal hyperplasia.
    Tirendi A; Traggiai C; Conway GS; Stanhope R
    Eur J Pediatr; 2002 Oct; 161(10):556-8. PubMed ID: 12297904
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of treatment on growth in congenital adrenal hyperplasia.
    Ercan O; Hatemi S; Kutlu E; Turan N
    Indian J Pediatr; 2000 Nov; 67(11):783-9. PubMed ID: 11216375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty.
    Stikkelbroeck NM; Van't Hof-Grootenboer BA; Hermus AR; Otten BJ; Van't Hof MA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3525-30. PubMed ID: 12915631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth in congenital adrenal hyperplasia.
    Nguyen AT; Brown JJ; Warne GL
    Indian J Pediatr; 2006 Jan; 73(1):89-93. PubMed ID: 16444069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid therapy in the neonatal period.
    Klevit HD
    Pediatr Clin North Am; 1970 Nov; 17(4):1003-13. PubMed ID: 5530741
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult congenital adrenal hyperplasia.
    Bozzola M
    Horm Res; 2007; 68 Suppl 5():154. PubMed ID: 18174735
    [No Abstract]   [Full Text] [Related]  

  • 13. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth.
    Jansen M; Wit JM; van den Brande JL
    Acta Paediatr Scand; 1981 Mar; 70(2):229-33. PubMed ID: 7015786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth characteristics in children with congenital adrenal hyperplasia.
    Alzanbagi MA; Milyani AA; Al-Agha AE
    Saudi Med J; 2018 Jul; 39(7):674-678. PubMed ID: 29968889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perioperative substitution therapy in congenital adrenogenital syndrome with salt loss].
    Abel M; von Petrykowski W
    Anaesthesist; 1984 Aug; 33(8):374-6. PubMed ID: 6486393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
    Bailey CC; Komrower GM
    Arch Dis Child; 1974 Jan; 49(1):4-7. PubMed ID: 4361889
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent obesity and short final height after corticoid overtreatment for congenital adrenal hyperplasia (CAH) in infancy.
    Knorr D; Hinrichsen de Lienau SG
    Acta Paediatr Jpn; 1988; 30 Suppl():89-92. PubMed ID: 3146883
    [No Abstract]   [Full Text] [Related]  

  • 18. Giant ovarian cyst in a woman with congenital adrenal hyperplasia disappeared after adjustment of glucocorticoid therapy.
    Wakakuri H; Kahara T; Shimizu A; Kanamoto A; Ishikura K; Usuda R
    Intern Med; 2010; 49(10):955-6. PubMed ID: 20467184
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W; Schmidt H; Schwarz HP
    Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth impairment in a boy with late-onset congenital adrenal hyperplasia and anorexia nervosa.
    Niedziela M; Sippell W
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):180-3. PubMed ID: 20198557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.